This result suggests that, to a certain degree, the necrotic and cystic components may facilitate the discrimination between IDH-mutated tumors and IDH-wild gliomas, but their performance is weaker than the inhomogenity. This evidence concerns the gene IDH2 and central nervous system cancer.